ReviewViruses2022

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication.

Ralph A Tripp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.